Copy Link Print Information

A 83-01

134 Cited Publications
Revisión del cliente

Based on 134 publication(s) in Google Scholar

A 83-01 is a potent inhibitor of TGF-β type I receptor ALK5 kinase, type I nodal receptor ALK4 and type I nodal receptor ALK7, with IC50s of 12 nM, 45 nM and 7.5 nM against the transcription induced by ALK5, ALK4 and ALK7, respectively.

Para uso exclusivo en investigación. No vendemos a pacientes.

  • Pureza: 99.41%
  • No. CAS: 909910-43-6
  • Fòrmula: C25H19N5S
  • Peso molecular:421.52
  • Almacenamiento:

    -20°C, protect from light, stored under nitrogen

    * The compound is unstable in solutions, freshly prepared is recommended.

  • A 83-01 Chemical Structure
  • Experimental Validation Results for A 83-01
  • Experimental Validation Results for A 83-01
  • Experimental Validation Results for A 83-01
  • Experimental Validation Results for A 83-01
  • Experimental Validation Results for A 83-01
  • A 83-01 Chemical Structure
    A 83-01 Chemical Structure
  • Experimental Validation Results for A 83-01
  • Experimental Validation Results for A 83-01
  • Experimental Validation Results for A 83-01
  • Experimental Validation Results for A 83-01
  • Experimental Validation Results for A 83-01
No. CAS: 909910-43-6
Tamaño
Precio
Stock
Cantidad
Amount: USD 0.00
Please select quantity
or
or

* Seleccione Cantidad antes de agregar artículos.

To place orders, for customer services and technical support, please contact: MedChemExpress USA

Tel: 609-228-6898 E-mail: [email protected] [email protected]

Data Download
Other Forms of A 83-01:

To place orders, for customer services and technical support, please contact:

609-228-6898
[email protected] [email protected]
Encuentre su distribuidor local Your local distributor: Hycultec GmbHHycultec
  • Actividad biológica
  • Chemical Information
  • Solvente y solubilidad
  • Protocolo
  • Pureza y Documentación
  • Referencias
  • Help & FAQs
You May Still Need
Top Publications Citing

Use of MCE Products

Publications Citing Use of MedChemExpress (MCE) A 83-01

More
Customer Validation & Images
IFWBRT-PCRCell Proliferation/Viability Assay
  • RT-PCR
  • IF
  • Cell Proliferation/Viability Assay
  • IF
  • WB

Ver todos los productos específicos de isoformas TGF-β Receptor

More
Keywords
100 mg

Obtener un presupuesto En stock

Please select quantity
Price: USD 0.00
Sign in to MedChemExpress Inicie sesiòn
Registrar
Sign in to MedChemExpress
Registrar una cuenta nueva

At least 6 characters

Personalize your experience, you are currently not signed in. For a better experience, please create an online profile, you can:

Obtain points redemption prizes
Check out faster
Add multiple shipping locations
View orders
Assay Types
  • A 83-01 Chemical Structure
    A 83-01 Chemical Structure
    1/16
  • 1/16

    A 83-01 purchased from MedChemExpress. Usage Cited in: Cancer Res. 2025 May 2;85(9):1628-1643. [Abstract]

    Customer Validation
     A83-01 (10 μM; 12 h) suppresses the expression of XYLT1 in bone-metastatic A549 cells.

  • 1/16

    A 83-01 purchased from MedChemExpress. Usage Cited in: Nat Genet. 2024 Feb;56(2):294-305. [Abstract]

    Customer Validation
     Trophoblast organoids constructed from hTSCs-BL. Trophoblast markers: CDH1 and hCG. Briefly, hTSCs were cultured in hTSCs medium (DMEM/F12 supplemented with 0.1 mM 2-mercaptoethanol, 0.2% FBS, 0.5% Penicillin–Streptomycin, 0.3% BSA, 1% ITS-X supplement, 1.5 μg/ml L-ascorbicacid, 50 ng/mL Epidermal Growth Factor (EGF)(MedChemExpress), 2 μM CHIR99021 (MedChemExpress), 0.5 μM A83-01 (MedChemExpress), 1 μM SB431542 (MedChemExpress), 0.8 mM Valproic acid and 5 μM Y27632 (MedChemExpress).

  • 1/16

    A 83-01 purchased from MedChemExpress. Usage Cited in: Genome Med. 2024 Apr 24;16(1):60. [Abstract]

    Customer Validation
     Cell viability assessment in the AtT20 cell line treated with Activin A (10 ng/ml) in the presence or absence of SB-505124 (1 μM), A 83–01 (1 μM; 24-96 h), or follistatin (100 ng/ml). K Cell viability analysis in AtT20 cell line with shEV-GFP or shAcvr1b treated with Activin A (10 ng/ml).

  • 1/16

    A 83-01 purchased from MedChemExpress. Usage Cited in: FASEB J. 2020 Aug;34(8):11185-11199. [Abstract]

    Customer Validation
     Changes in the expression of E-Cadherin (green) and Vimentin (red) are detected by immunofluorescence. TGF-β1-induced changes in the expression of protein markers during EMT were blocked after A83-01 treatment.

  • 1/16

    A 83-01 purchased from MedChemExpress. Usage Cited in: Gynecol Oncol. 2019 Jun;153(3):639-650. [Abstract]

    Customer Validation
     Analysis of E-cadherin, N-cadherin,MMP-2 and pSmad2 in SK-OV-3 and OVCAR-3 cells treated with platelets, A83-01 or their combination at protein levels (n=3). GAPDH is used as loading control.

  • A 83-01